Clinical Trials Directory

Trials / Unknown

UnknownNCT02850445

Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients

Effects of Integrated Treatment for Chinese Patients With Schizophrenia: 1-year Follow-up

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Guangzhou Psychiatric Hospital · Other Government
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Regular psychosocial intervention combined with antipsychotic drugs, compared with usual medication alone treatments, can reduce psychiatric symptoms and improve quality of life in patients with schizophrenia. However, it's expensive, time-consuming, and sometimes inconvenient for patients and their family members in developing areas where the number of well-trained therapist remains limited in local psychiatric settings. The investigators aimed to establish an efficient model of integrated treatment (IT) for patients with schizophrenia. The procedure contains two stages: a centralized treatment during hospitalization and the following consolidation treatments with long intervals.

Conditions

Interventions

TypeNameDescription
DRUGOlanzapineAll patients with schizophrenia were under medication treatment at the baseline. Individualized plan of antipsychotic medication for the patients were determined by psychiatrist who were blind to the group allocation. Medications could be changed at any time during the course of the study if the change was clinically warranted, the drug can also be any other antipsychotic medication.
OTHERCognitive behavior therapyPatients with schizophrenia allocated to the Integrated Treatment(IT) group received Cognitive behavioral therapy.
OTHERRehabilitation treatmentRehabilitation treatment include three modules: medication management, symptom management, and social kill training. Patients with schizophrenia allocated to the Integrated Treatment(IT) group received Rehabilitation treatment therapy.
OTHERCase managementPatients with schizophrenia allocated to the Integrated Treatment(IT) group received Case management.

Timeline

Start date
2012-01-01
Primary completion
2016-12-01
First posted
2016-08-01
Last updated
2016-08-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02850445. Inclusion in this directory is not an endorsement.